carbon monoxide has been researched along with bupropion in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (60.00) | 29.6817 |
2010's | 8 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angliss, M; Lee, L; Leslie, K; Mezzavia, P; Myles, PS | 1 |
Barrueco, M; Jiménez Ruiz, C; Palomo, L; Riesco, JA; Romero, P; Torrecilla, M | 1 |
Eisenberg, MJ; Ludvig, J; Miner, B | 1 |
Evans, A; Gibson, J; Henderson, M; Wilkes, S | 1 |
Heasman, L; Heasman, PA; Nasry, HA; Preshaw, PM; Stacey, F; Swan, M | 1 |
Beamonte, A; Gargallo, P; Jiménez-Muro, A; Marqueta, A; Nerín, I | 1 |
Birnbaum, A; Cather, C; Culhane, MA; Evins, AE; Freudenreich, O; Goff, DC; Henderson, DC; Horowitz, J; Hsieh, E; Rigotti, NA; Schoenfeld, DA | 1 |
Lancaster, T; Stead, LF | 1 |
Jatlow, P; Krishnan-Sarin, S; Leary, V; O'Malley, SS; Toll, BA | 1 |
Arredondo, C; Celio, M; Cromp, D; Fong, D; Fortmann, SP; Hayward, C; Killen, JD; Murphy, G; Pandurangi, M; Schatzberg, AF | 1 |
Hering, T | 1 |
Groman, E; Kunze, U; Riemerth, A | 1 |
Arteaga, C; Brandon, TH; Gonzales, D; Jorenby, DE; Lee, TC | 1 |
Kaplan, GB; Reid, N; Rohsenow, DJ; Swift, RM; Tidey, JW | 1 |
Advani, M; Cabezas, C; Martin, C; Puente, D; Rodriguez-Blanco, T | 1 |
Chengappa, KN; Jao, NC; Karelitz, JL; Lerman, C; Perkins, KA; Sparks, GM | 1 |
Bondade, S; Chandrashekar, M; Kumar, KK; Sattar, FA | 1 |
Badger, GJ; Heil, SH; Higgins, ST; Meyer, AC; Miller, ME; Saulsgiver, K; Sigmon, SC | 1 |
Begh, R; Fanshawe, TR; Farley, A; Hartmann-Boyce, J; Lancaster, T; Lindson-Hawley, N | 1 |
Boffi, R; Colombo, F; Galvan, A; Noci, S; Pasetti, G; Pastorino, U; Pintarelli, G; Pozzi, P; Sala, F | 1 |
3 review(s) available for carbon monoxide and bupropion
Article | Year |
---|---|
Smoking cessation in patients with coronary artery disease.
Topics: Administration, Cutaneous; Administration, Inhalation; Administration, Oral; Atherosclerosis; Behavior Therapy; Bupropion; Carbon Monoxide; Coronary Disease; Double-Blind Method; Hemodynamics; Humans; Hypoxia; Nicotine; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Thrombophilia; Tobacco Use Disorder; Vasoconstriction | 2005 |
Interventions to reduce harm from continued tobacco use.
Topics: Biomarkers; Bupropion; Carbon Monoxide; Cotinine; Humans; Nicotine; Nicotinic Agonists; Smoking; Smoking Cessation; Smoking Prevention | 2007 |
Interventions to reduce harm from continued tobacco use.
Topics: Biomarkers; Bupropion; Carbon Monoxide; Cotinine; Electronic Nicotine Delivery Systems; Humans; Nicotine; Nicotinic Agonists; Randomized Controlled Trials as Topic; Smoking; Smoking Cessation; Smoking Prevention; Tobacco Use Cessation Devices; Tobacco Use Disorder | 2016 |
9 trial(s) available for carbon monoxide and bupropion
Article | Year |
---|---|
Effectiveness of bupropion as an aid to stopping smoking before elective surgery: a randomised controlled trial.
Topics: Adult; Bupropion; Carbon Monoxide; Double-Blind Method; Elective Surgical Procedures; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxygen; Preoperative Care; Prospective Studies; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2004 |
A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Psychiatric Status Rating Scales; Sample Size; Schizophrenia; Schizophrenic Psychology; Smoking Cessation | 2007 |
Comparison of expired carbon monoxide and plasma cotinine as markers of cigarette abstinence.
Topics: Adult; Antidepressive Agents, Second-Generation; Breath Tests; Bupropion; Carbon Monoxide; Cotinine; Delayed-Action Preparations; Female; Humans; Male; Reproducibility of Results; Smoking; Smoking Cessation | 2008 |
Extended cognitive behavior therapy for cigarette smoking cessation.
Topics: Adult; Bupropion; Carbon Monoxide; Cognitive Behavioral Therapy; Counseling; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Patient Compliance; Smoking Cessation; Substance Withdrawal Syndrome | 2008 |
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Topics: Adolescent; Adult; Aged; Benzazepines; Breath Tests; Bupropion; Carbon Monoxide; Delayed-Action Preparations; Dopamine Uptake Inhibitors; Drug Labeling; Female; Health Knowledge, Attitudes, Practice; Humans; Logistic Models; Male; Middle Aged; Motivation; Nicotinic Agonists; Placebos; Quinoxalines; Secondary Prevention; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Varenicline; Young Adult | 2010 |
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia.
Topics: Adult; Behavior Therapy; Behavior, Addictive; Breath Tests; Bupropion; Carbon Monoxide; Combined Modality Therapy; Cotinine; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Patient Dropouts; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Smoking; Smoking Cessation; Substance Withdrawal Syndrome | 2011 |
Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Breath Tests; Bupropion; Carbon Monoxide; Chewing Gum; Cluster Analysis; Counseling; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Motivation; Nicotine; Nicotinic Agonists; Primary Health Care; Program Evaluation; Psychological Theory; Smoking; Smoking Cessation; Social Class; Spain; Spouses; Time Factors; Transdermal Patch; Treatment Outcome; Young Adult | 2011 |
A comparative study of different modalities of treatment in nicotine dependence syndrome.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Behavior Control; Breath Tests; Brief Psychiatric Rating Scale; Bupropion; Carbon Monoxide; Combined Modality Therapy; Female; Humans; International Classification of Diseases; Male; Smoking Cessation; Tobacco Use Cessation Devices; Tobacco Use Disorder; Treatment Outcome | 2015 |
Financial incentives to promote extended smoking abstinence in opioid-maintained patients: a randomized trial.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Analgesics, Opioid; Breath Tests; Bupropion; Carbon Monoxide; Cotinine; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Motivation; Opioid-Related Disorders; Self Report; Smoking; Smoking Cessation; Smoking Prevention; Young Adult | 2016 |
8 other study(ies) available for carbon monoxide and bupropion
Article | Year |
---|---|
[Veracity of smokers' reports of abstinence at smoking cessation clinics].
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Data Interpretation, Statistical; Dopamine Uptake Inhibitors; Female; Humans; Longitudinal Studies; Male; Middle Aged; Motivation; Nicotine; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Smoking Cessation; Spain; Time Factors | 2005 |
Pragmatic, observational study of bupropion treatment for smoking cessation in general practice.
Topics: Adolescent; Adult; Age Distribution; Aged; Bupropion; Carbon Monoxide; Dopamine Uptake Inhibitors; Family Practice; Female; Humans; Male; Middle Aged; Prospective Studies; Smoking; Smoking Cessation; Smoking Prevention; Treatment Outcome | 2005 |
Smoking cessation advice for patients with chronic periodontitis.
Topics: Adult; Breath Tests; Bupropion; Carbon Monoxide; Central Nervous System Stimulants; Chronic Disease; Cohort Studies; Cotinine; Counseling; Dental Hygienists; Dopamine Uptake Inhibitors; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Nicotine; Patient Education as Topic; Periodontitis; Professional-Patient Relations; Saliva; Smoking; Smoking Cessation; Treatment Outcome | 2006 |
[Weight gain and anxiety levels in recent ex-smokers].
Topics: Adult; Anxiety; Basal Metabolism; Breath Tests; Bupropion; Carbon Monoxide; Chewing Gum; Feeding Behavior; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Prospective Studies; Psychological Tests; Smoking Cessation; Weight Gain | 2007 |
[Specific program for smoking cessation: thus your patients become nonsmokers].
Topics: Behavior Therapy; Benzazepines; Bupropion; Carbon Monoxide; Contraindications; Humans; Nicotinic Agonists; Physician-Patient Relations; Quinoxalines; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2008 |
Nocturnal sleep-disturbing nicotine craving and accomplishment with a smoking cessation program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Behavior Therapy; Breath Tests; Bupropion; Carbon Monoxide; Chi-Square Distribution; Child; Counseling; Female; Humans; Male; Middle Aged; Nicotine; Sleep Wake Disorders; Smoking Cessation; Surveys and Questionnaires; Time Factors; Tobacco Use Disorder | 2009 |
Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications.
Topics: Adult; Benzhydryl Compounds; Bupropion; Carbon Monoxide; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Mass Screening; Middle Aged; Modafinil; Self Report; Sensitivity and Specificity; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; United States; Wakefulness-Promoting Agents; Young Adult | 2013 |
Pharmacogenetic study of seven polymorphisms in three nicotinic acetylcholine receptor subunits in smoking-cessation therapies.
Topics: 5' Untranslated Regions; Adult; Aged; Bupropion; Carbon Monoxide; Exhalation; Female; Humans; Male; Middle Aged; Nerve Tissue Proteins; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Receptors, Nicotinic; Smoking; Smoking Cessation Agents; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline; Young Adult | 2017 |